BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 24, 2020
View Archived Issues
Ketamine and opioids
Read More
Link between lipid metabolism, cancer stem cell death and anti-tumor immunity mediated by ARF1
Read More
IGF1R inhibitors may find utility as head and neck squamous-cell carcinoma treatments
Read More
Noxafil approved in Japan for deep fungal infections
Read More
Dotinurad receives Japanese approval for hyperuricemia
Read More
AbbVie receives approval for Rinvoq in Japan
Read More
Thyradin S.I.V. Injection approved in Japan for myxedema coma and hypothyroidism
Read More
Virogin Biotech receives approval to initiate phase I study of VG-161 in Australia
Read More
AGTC reports interim data from ongoing phase I/II studies in achromatopsia
Read More
KEA-1010 retains analgesic and sedative potency in vivo
Read More
Results presented from phase III PENUT study of erythropoietin in preterm infants
Read More
Dayvigo approved in Japan for the treatment of insomnia
Read More
IFM Due discloses hSTING receptor antagonists
Read More
Shanghai Institute of Materia Medica patents GPR84 antagonists
Read More
Janssen Pharmaceutica NV patents prostanoid EP3 receptor antagonists
Read More
Daiichi Sankyo identifies new EGFR and/or HER2 mutant inhibitors
Read More
Metrion Biosciences describes new KCNA3 channel blockers
Read More
Study casts light on tumor initiating cells in breast cancer
Read More
Norbinaltorphimine shown efficacious for preclinical autism and ADHD
Read More
FDA grants accelerated approval of Tazverik for epithelioid sarcoma
Read More
Japanese approval for Corectim ointment for atopic dermatitis
Read More
Anerem approved in Japan for general anesthesia
Read More
BlackThorn initiates phase II proof-of-concept trial with BTRX-140 in major depressive disorder
Read More